A randomized controlled trial of buprenorphine taper duration among opioid‐dependent adolescents and young adults

201697 citationsJournal Article

Authors

Lisa A. Marsch · Dartmouth Psychiatric Research Center

Sarah K. Moore · Capital Health

Jacob T. Borodovsky · Dartmouth College

Ramon Solhkhah · Jersey Shore University Medical Center

Gary J. Badger · University of Vermont Medical Center

Shelby J. Semino · New York Public Library

Kate Jarrett

Abstract

Longer (56-day) buprenorphine taper produces better opioid abstinence and retention outcomes than shorter (28-day) buprenorphine taper for opioid-dependent youth.

Topics & Keywords

Opioid Use Disorder Treatment Substance Abuse Treatment and Outcomes Prenatal Substance Exposure Effects

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Addiction

Volume 111, Issue 8, pp. 1406-1415

DOI: 10.1111/add.13363

Field-Weighted Citation Impact: 9.08